Skip to main content
. Author manuscript; available in PMC: 2014 Feb 2.
Published in final edited form as: Am Heart J. 2012 Oct 29;164(6):862–868. doi: 10.1016/j.ahj.2012.08.019

Table 4.

Regression Model* to Predict Net Fluid Loss at 72 hours, including Clinical and Laboratory Covariates Assessed at or before Study Enrollment

Covariate P value
Age .02 (−)
Sex .07 (−)
LVEF .06 (+)
NYHA class .59 (−)
Baseline global VAS .51 (+)
Baseline hemoglobin .30 (−)
Serum sodium .45 (+)
Baseline BUN .24 (+)
Baseline troponin I .69 (−)
Baseline NT-proBNP .27 (+)
Baseline cystatin C .06 (−)
Baseline creatinine .32 (−)
Furosemide dose Interaction factor
Continuous mode of therapy Interaction factor
Continuous mode × outpatient dose .0028 (−)
High initial IV diuretic dose .0007 (+)
*

198 patients had data available for this model.

Abbreviations: BUN, blood urea nitrogen; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro-B-type natriuretic peptide, NYHA, New York Heart Association; VAS, visual analog scale. The (+) and (−) after the P values signify the directionality of the regression

HHS Vulnerability Disclosure